alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                     National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Review.                

*Date:*                     March 29, 2024.                

*Time:*                     1:00 p.m. to 5:00 p.m.                

*Agenda:*                     To review and evaluate grant applications.                

*Place:*                     National Institutes of Health, NIDDK, Democracy II, Suite 7000A, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).                

*Contact Person:*                     Paul A. Rushing, Ph.D., Scientific Review Officer, Review Branch, Division of Extramural Activities, NIDDK, National Institutes of Health, Room 7345, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-8895,                     *rushingp@extra.niddk.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS)

Dated: January 25, 2024. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2024-01850 Filed 1-30-24; 8:45 am]

BILLING CODE 4140-01-P
|   | (1) | The                Report fully complies with the requirements of section 13(a) or 15(d)                of                the Securities Exchange Act of 1934;                and |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (2) | The                information contained in the Report fairly presents, in all material                respects, the financial condition and result of operations of the                Company. |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                                                              |   |   |   |
|-------------------------------------------------------------------|--------|--------|--------|
| */s/              Michael              Karpheden*                 |   |   |   |
| Michael              Karpheden                                    |   |   |        |
| Chief                Financial OfficerMay                10, 2006 |   |   |   |
Exhibit 31.2

     Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Thomas D. Davis, certify that:

     1. I have reviewed this annual report of Xybernaut Corporation;

     2. Based on my knowledge, this annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this annual
report;

     3. Based on my knowledge, the financial statements, and other financial
information included in this annual report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this annual report;

     4. The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

     (a) Designed such disclosure controls and procedures, or caused such
     disclosure controls and procedures to be designed under our supervision, to
     ensure that material information relating to the registrant, including its
     consolidated subsidiaries, is made known to us by others within those
     entities, particularly during the period in which this annual report is
     being prepared;

     (b) Evaluated the effectiveness of the registrant's disclosure controls and
     procedures and presented in this report our conclusions about the
     effectiveness of the disclosure controls and procedures, as of the end of
     the period covered by this report based on such evaluation; and

     (c) Disclosed in this report any change in the registrant's internal
     control over financial reporting that occurred during the registrant's most
     recent fiscal quarter that has materially affected, or is reasonably likely
     to materially affect, the registrant's internal control over financial
     reporting; and

     5. The registrant's other certifying officers and I have disclosed, based
on our most recent evaluation of internal control over financial reporting, to
the registrant's auditors and the audit committee of the registrant's board of
directors (or persons performing the equivalent functions):

     (a) All significant deficiencies and material weaknesses in the design or
     operation of internal control over financial reporting which are reasonably
     likely to adversely affect the registrant's ability to record, process,
     summarize and report financial information; and

     (b) Any fraud, whether or not material, that involves management or other
     employees who have a significant role in the registrant's internal control
     over financial reporting.

April 26, 2004


XYBERNAUT CORPORATION


By: /s/ THOMAS D. DAVIS
-----------------------
Thomas D. Davis
Senior Vice President and
Chief Financial Officer
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 95-7006

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

versus

J. C. LEE, III,

Defendant - Appellant.

Appeal from the United States District Court for the Eastern District of North Carolina, at Raleigh. W. Earl Britt, District Judge.

(CR-94-16-BR, CA-95-370-BR)

Submitted: August 22, 1996 Decided: September 3, 1996

Before RUSSELL, HALL, and WILLIAMS, Circuit Judges.

Affirmed by unpublished per curiam opinion.

J. C. Lee, III, Appellant Pro Se. Jane H. Jolly, Assistant United

States Attorney, Raleigh, North Carolina, for Appellee.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
2

PER CURIAM:

Appellant appeals from the district court's order denying his

28 U.S.C. § 2255 (1988) motion. We have reviewed the record and the

district court's opinion and find no reversible error. Accordingly,

we affirm on the reasoning of the district court. United States v.

Lee, Nos. CR-94-16-BR; CA-95-370-BR (E.D.N.C. May 4, 1995). We

dispense with oral argument because the facts and legal contentions

are adequately presented in the materials before the court and

argument would not aid the decisional process.

AFFIRMED
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Health Resources and Services Administration

# AGENCY:

Health Resources and Services Administration (HRSA), Department of Health and Human Services.

# ACTION:

Notice; correction.

# SUMMARY:

                        HRSA published a notice in the                         **Federal Register**                         on October 12, 2023, concerning the 2024 calendar year meetings of the Advisory Commission on Childhood Vaccines (ACCV). The meeting times have changed. The 2024 ACCV meetings will be held from 1 p.m. eastern time (ET)-4 p.m. ET instead of from 10 a.m.-4 p.m.                    

# FOR FURTHER INFORMATION CONTACT:

                        Pita Gomez, Principal Staff Liaison, Division of Injury Compensation Programs, HRSA, 5600 Fishers Lane, 8W-25A, Rockville, Maryland 20857; 800-338-2382; or                         *ACCV@hrsa.gov.*

# SUPPLEMENTARY INFORMATION:

## Correction

                    In the                     **Federal Register**                     of October 12, 2023, FR Doc. 2023-22584, page 70680, column 2, correct the Dates caption to read: “The ACCV meetings will be held on:                
    - March 7, 2024, 1 p.m. ET-4 p.m. ET;
    - March 8, 2023, 1 p.m. ET-4 p.m. ET;
    - September 5, 2023, 1 p.m. ET-4 p.m. ET;
    - September 6, 2023, 1 p.m. ET-4 p.m. ET.”

Maria G. Button,

Director, Executive Secretariat.

[FR Doc. 2024-02106 Filed 2-1-24; 8:45 am]

BILLING CODE 4165-15-P
**Exhibit 32.2**

 

**CERTIFICATION OF CHIEF FINANCIAL OFFICER**

 

**PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTEDPURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

Theundersigned, Thomas E. Dunn the Chief Financial Officer of SI International,Inc. (the “Company”), has executed this certification in connection with thefiling with the Securities and Exchange Commission of the Company’s QuarterlyReport on Form 10-Q for the quarter and six months ending June 28, 2003 (the“Report”).  The undersigned hereby certifiesthat:

 

(1)                        theReport fully complies with the requirements of Section 13(a) or 15(d) of theSecurities Exchange Act of 1934; and

 

(2)                        theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of the Company.

 

 
| Date: August 11, 2003 | /s/    |                                          |
|-----------------------|--------|-----------------------------------------------|
|                  | Name:  | Thomas  E. Dunn                               |
|                  | Title: | EVP,  Chief Financial Officer & Treasurer |
|                       |        |                                               |  |

 

----
II

104TH CONGRESS

2D SESSION S. 1987

To amend titles II and XVIII of the Social Security Act to prohibit the

use of Social Security and Medicare trust funds for certain expenditures

relating to union representatives at the Social Security Administration

and the Department of Health and Human Services.

IN THE SENATE OF THE UNITED STATES

JULY 24, 1996

Mr. FAIRCLOTH introduced the following bill; which was read twice and

referred to the Committee on Finance

A BILL

To amend titles II and XVIII of the Social Security Act

to prohibit the use of Social Security and Medicare trust

funds for certain expenditures relating to union representatives at the Social Security Administration and

the Department of Health and Human Services.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,
2

•S 1987 IS

1 SECTION 1. PROHIBITION OF USE OF SOCIAL SECURITY

2 AND MEDICARE TRUST FUNDS FOR EXPENDI3 TURES RELATING TO UNION REPRESENTA4 TIVES AT SOCIAL SECURITY ADMINISTRA5 TION AND DEPARTMENT OF HEALTH AND

6 HUMAN SERVICES.

7 (a) SOCIAL SECURITY ADMINISTRATION.—Section

8 201(g)(1)(A) of the Social Security Act (42 U.S.C.

9 401(g)(1)(A)) is amended by adding at the end the follow10 ing new sentence: ‘‘Nothing in the preceding sentence shall

11 be construed to authorize the use of the Trust Funds for

12 expenditures for official time for employees of the Social

13 Security Administration pursuant to section 7131 of title

14 5, United States Code, or for facilities or support services

15 for labor organizations pursuant to policies, regulations,

16 or procedures referred to in section 7135(b) of such title.’’.

17 (b) DEPARTMENT OF HEALTH AND HUMAN SERV18 ICES.—

19 (1) Section 1817(h) of the Social Security Act

20 (42 U.S.C. 1395i(h)) is amended by adding at the

21 end the following new sentence: ‘‘Nothing in the pre22 ceding sentence shall be construed to authorize the

23 use of the Trust Fund for expenditures for official

24 time for employees of the Department of Health and

25 Human Services pursuant to section 7131 of title 5,

26 United States Code, or for facilities or support serv-
3

•S 1987 IS

1 ices for labor organizations pursuant to policies, reg2 ulations, or procedures referred to in section

3 7135(b) of such title.’’.

4 (2) Section 1841(g) of the Social Security Act

5 (42 U.S.C. 1395t(g)) is amended by adding at the

6 end the following new sentence: ‘‘Nothing in the pre7 ceding sentence shall be construed to authorize the

8 use of the Trust Fund for expenditures for official

9 time for employees of the Department of Health and

10 Human Services pursuant to section 7131 of title 5,

11 United States Code, or for facilities or support serv12 ices for labor organizations pursuant to policies, reg13 ulations, or procedures referred to in section

14 7135(b) of such title.’’.

15 (c) EFFECTIVE DATE.—The amendments made by

16 this section shall apply to any collective bargaining agree17 ment entered into after the date of the enactment of this

18 Act.

Æ
#### Benny VASQUEZ, Appellant, v. The STATE of Texas, Appellee.

*No. 28224.*

Court of Criminal Appeals of Texas.

April 4, 1956.

*576No appearance for appellant.

Leon B. Douglas, State’s Atty., Austin, for the State.

PER CURIAM.

The conviction, on a plea of guilty, is for the sale of beer in a dry area under three counts. The court found him guilty under each count and assessed a total fine of $375.

The record on appeal contains no statement of facts or bills of exception. All proceedings appear to be regular and nothing is presented for review. ,

The judgment is affirmed.
Exhibit
      32.2





CERTIFICATION
      PURSUANT TO


18
      U.S.C.
      SECTION 1350,


AS
      ADOPTED PURSUANT TO


SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002





In
      connection with the Quarterly Report of Celsia Technologies, Inc. (the
“Company”) on Form 10-Q for the period ending March 31, 2008 as filed with
      the Securities and
      Exchange Commission on the date hereof (the “Report”), I, Jorge Fernandez, Chief
      Financial Officer of the Company, certify pursuant to 18 U.S.C. § 1350, as
      adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to the best of
      my knowledge:




(1)
            The
                Report fully complies with the requirements of section 13(a) or 15(d)
                of
                the Securities Exchange Act of 1934;
                and




(2)
            The
                information contained in the Report fairly presents, in all material
                respects, the financial condition and result of operations of the
                Company.





/s/
                Jorge A. FernandezJorge
                A. FernandezChief
                Financial OfficerMay
                13, 2008
<PAGE>
                              EXHIBIT 23.1 Consent of PricewaterhouseCoopers LLP


                       CONSENT OF INDEPENDENT ACCOUNTANTS


     We hereby consent to the incorporation by reference in the Registration
Statement on Forms S-3 (File No. 333-31046, File No. 333-48664, File No.
333-61832, and File No. 333-69718) and Forms S-8 (File No. 333-75351, File No.
333-34999, File No. 333-83225, File No. 333-95569, File No. 333-60148, File No.
333-81856, File No. 333-81854, and File No. 333-64144) of AdvancePCS of our
report dated May 15, 2002, except with respect to the matter discussed in Note
16, as to which the date is June 5, 2002, relating to the financial statements
and financial statement schedule, which appears in this Form 10-K. We also
consent to the reference to us under the heading "Selected Historical Financial
and Operating Data" in this Form 10-K.

/s/ PricewaterhouseCoopers LLP

Dallas, Texas
June 28, 2002
Exhibit 32.1



Statement



Pursuant to §906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. §1350, the undersigned officer of Appleton Papers Inc. (the Company),
hereby certifies that to his knowledge:



| | (1) | the Companys Quarterly Report on Form 10-Q for the quarter ended April 4, 2004 fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities
Exchange Act of 1934, and
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | (2) | the information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                    |  |  |  |                      |  |                        |  |                                                
|------------------- |  |  |  | -------------------- |  | ---------------------- |  | -----------------------------------------------
|                    |  |  |  | APPLETON PAPERS INC.
|                    |  |  | 
|Dated: May 17, 2004 |  |  |  |                      |  | /s/    DOUGLAS P. BUTH
|                    |  |  |  |                      |  |                        | 
|                    |  |  |  |                      |  | Name:                  |  | Douglas P. Buth                                
|                    |  |  |  |                      |  | Title:                 |  | Chairman, President and Chief Executive Officer



This certification accompanies this
Quarterly Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of the Securities Exchange Act of 1934.
10

1_RCP_Ref GCAM RCP Reference Scenario (the no climate policy scenario associated with the RCP4.5) Year Foss CO2 Defo CO2 CH4 N2O NOx VOCs CO SO2,1 SO2,2 SO2,3 CF4 C2F6 HFC125 HFC134a HFC143a HFC227ea HFC245ca SF6 Year (Pg C) (Pg C) (Tg) (Tg N) (Mt N) (Mt) (Mt) (Tg S) (Tg S) (Tg S) (kton) (kton) (kton) (kton) (kton) (kton) (kton) (kton) 1990 6.055 1.599 273.903 6.955 37.8 206.246 1040.263 0 0 0 18.929 1.028 0.001 0 0 0 0 6.327 2000 7.259 1.265 292.239 7.497 38.449 215.385 1075.392 -7.063 5.988 2.197 17.31 1.888 5.167 158.773 0 0 12.076 6.228 2005 7.861 1.097 301.407 7.767 38.774 219.954 1092.956 -10.595 8.983 3.295 16.5 2.317 7.75 238.159 0 0 18.114 6.179 2020 10.368 0.706 359.462 9.092 37.985 226.176 1168.149 -17.55 11.922 3.942 13.011 1.464 17.705 428.249 0 0 67.225 5.274 2035 13.277 0.667 404.647 10.149 38.248 252.481 1228.739 -20.784 4.751 4.569 14.793 1.781 22.512 561.325 0 0 73.986 6.827 2050 15.747 0.682 434.962 10.692 33.993 237.614 1103.437 -23.347 -3.478 3.704 16.251 2.084 27.532 698.516 0 0 77.834 8.103 2065 17.765 0.629 447.064 11.005 29.963 224.33 959.171 -23.982 -7.669 3.875 17.847 2.365 33.962 873.606 0 0 80.517 8.943 2080 19.849 0.335 443.502 10.938 26.247 188.46 704.275 -24.379 -10.171 2.555 19.463 2.551 42.184 1098.506 0 0 83.552 9.716 2095 21.392 0.29 446.853 10.823 24.817 173.182 593.608 -24.544 -10.737 0.602 20.983 2.693 50.563 1311.98 0 0 85.08 10.24 2100 21.392 0.29 446.853 10.823 24.817 173.182 593.608 -24.544 -10.737 0.602 20.983 2.693 50.563 1311.98 0 0 85.08 10.24 X12345123456789012345678901234567890123456789012345678901234567890123456789012345678901234567890123456789012345678901234567890123456789012345678901234567890123456789012345678901234567890 Produced by write_magicc_file.R from ../R/EPA_Baseline.csv. JGCRI/PNNL, Thu Jun 21 22:05:38 2012